Article Information
History
- July 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jannik Stemler, MD1,2,3,*,
- Jon Salmanton-García, PhD1,2,
- Ben Weise1,2,
- Christina Többen1,2,
- Carolin Joisten1,2,
- Julian Fleig1,2,
- Prof. Oliver A. Cornely, MD1,2,3,4 and
- the VACCELERATE Consortium
- 1University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Herderstrasse 52, 50931 Cologne, Germany
- 2University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Kerpener Str. 62, 50937 Cologne, Germany
- 3German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Kerpener Str. 62, 50937 Cologne, Germany
- 4University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Gleueler Str. 269, 50935 Cologne, Germany
- ↵*Correspondence to:
Jannik Stemler, MD, University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany, Herderstr. 52-54, 50931 Cologne, Germany, Phone: +49 (0) 221 478 85523, E-mail: Jannik.Stemler{at}uk-koeln.de
Posted July 18, 2022.
A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022
